Genmab — Marts 2019
-
-
God morgen.
-
SNIPR BIOME
We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
SNIPR BIOME (www.sniprbiome.com)
-
Tilbagefaldet behøver jo ikke at køre ned i 950?
-
Tilbagefaldet må meget gerne køre længere ned end 950... jeg har lidt overskuds-skat som skal brændes af!
-
A/B har været største køber i et pænt stykke tid. I dag er der en eller flere fra gruppen som hælder ud.
-
Lidt mystisk bare at sælge ned gennem hylderne på den måde.¨
-
Den har de brugt før. F.eks. forleden dag.
-
Media Release
Copenhagen, Denmark, March 11, 2019
Genmab A/S (Nasdaq Copenhagen: GEN) announced today that Marisol Peron has
been appointed Corporate Vice President, Communications and Investor
Relations, effective March 11, 2019. Ms. Peron will be responsible for the
strategic management of both internal and external communications and
investor relations efforts for Genmab. Andrew Carlsen, who recently joined
the company as Senior Director Investor Relations, continues to be the
contact point
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind